Jumei Shi Selected Research

Drug Therapy (Chemotherapy)

1/2020	Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma.
8/2018	Targeting the PI3K/Akt/mTOR signaling pathway by pterostilbene attenuates mantle cell lymphoma progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jumei Shi Research Topics

Disease

35	Multiple Myeloma 12/2023 - 02/2008
32	Neoplasms (Cancer) 04/2024 - 02/2008
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2023 - 11/2015
7	Lymphoma (Lymphomas) 02/2024 - 05/2016
5	T-Cell Leukemia (Leukemia, T Cell) 06/2020 - 06/2014
4	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 11/2016
3	B-Cell Lymphoma (Lymphoma, B Cell) 06/2020 - 06/2017
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 08/2018 - 08/2018
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2015 - 06/2014
2	Leukemia 06/2014 - 01/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2023
1	Carcinogenesis 09/2023
1	Tics (Tic) 01/2020
1	Pathologic Complete Response 01/2020
1	Residual Neoplasm 01/2020
1	Thrombosis (Thrombus) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Fascioliasis 01/2019
1	Chromosomal Instability (Chromosome Stability) 04/2017
1	Venous Thromboembolism 08/2016
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 05/2016
1	Proteinuria 01/2015
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2015
1	Smoldering Multiple Myeloma 01/2015
1	Fatigue 01/2014
1	Constipation 01/2014

Drug/Important Bio-Agent (IBA)

6	Bortezomib (Velcade)FDA Link 11/2023 - 02/2008
6	pterostilbeneIBA 04/2020 - 11/2016
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2013
5	Proteasome InhibitorsIBA 09/2023 - 02/2008
4	DCZ3301IBA 06/2020 - 01/2017
4	Histone Deacetylase InhibitorsIBA 01/2020 - 06/2014
4	LigandsIBA 04/2013 - 12/2008
3	DCZ0358IBA 12/2023 - 01/2018
3	PanobinostatIBA 01/2020 - 01/2015
3	carfilzomibIBA 05/2016 - 06/2014
2	ResveratrolIBA 05/2021 - 11/2016
2	SiliconesIBA 01/2021 - 01/2020
2	RafoxanideIBA 02/2020 - 01/2019
2	Melphalan (Alkeran)FDA LinkGeneric 01/2020 - 12/2008
2	ATPases Associated with Diverse Cellular ActivitiesIBA 01/2020 - 04/2017
2	IronIBA 01/2019 - 06/2015
2	Mechanistic Target of Rapamycin Complex 1IBA 08/2018 - 01/2018
2	5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA 08/2018 - 11/2016
2	Matrix Metalloproteinases (MMPs)IBA 07/2018 - 06/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2016 - 06/2014
2	Vorinostat FDA Link 05/2016 - 06/2014
2	HLA Antigens (Human Leukocyte Antigens)IBA 07/2014 - 02/2008
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024
1	Cantharidin (Cantharides)IBA 12/2023
1	Adenosine Triphosphate (ATP)IBA 12/2023
1	Etoposide (VP 16)FDA LinkGeneric 12/2023
1	Pain-FreeIBA 12/2023
1	norcantharidinIBA 11/2023
1	bafilomycin A1IBA 10/2023
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 09/2023
1	ribosomal protein S3IBA 09/2023
1	AlkaloidsIBA 02/2023
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 05/2022
1	FlavonoidsIBA 11/2021
1	QuercetinIBA 11/2021
1	LuciferasesIBA 05/2021
1	osalmideIBA 04/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2020
1	Therapeutic UsesIBA 01/2020
1	ruxolitinibIBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2019
1	Type III Secretion SystemsIBA 01/2019
1	metal transporting protein 1 (ferroportin)IBA 01/2019
1	LipopolysaccharidesIBA 01/2019
1	InflammasomesIBA 01/2019
1	Mechanistic Target of Rapamycin Complex 2IBA 08/2018
1	sotrastaurinIBA 04/2018
1	Cytotoxins (Cytolysins)IBA 10/2017
1	Rituximab (Mabthera)FDA Link 06/2017
1	Dobutamine FDA LinkGeneric 12/2016
1	MitogensIBA 12/2016
1	Protein Kinases (Protein Kinase)IBA 11/2016
1	AntioxidantsIBA 11/2016
1	JNK Mitogen-Activated Protein KinasesIBA 11/2016
1	Thalidomide (Thalomid)FDA Link 08/2016
1	fucoidanIBA 11/2015
1	CateninsIBA 02/2015
1	ibrutinibIBA 02/2015
1	CGI 1746IBA 02/2015
1	Agammaglobulinaemia Tyrosine KinaseIBA 02/2015
1	Immunoglobulin A (IgA)IBA 01/2015
1	HLA-G Antigens (HLA G)IBA 07/2014
1	Cytochromes c (Cytochrome c)IBA 06/2014
1	Caspase 9IBA 06/2014
1	Protein Isoforms (Isoforms)IBA 06/2014

Therapy/Procedure

13	Therapeutics 12/2023 - 01/2015
4	Intraperitoneal Injections 04/2020 - 11/2016
2	Drug Therapy (Chemotherapy) 01/2020 - 08/2018
2	Stem Cell Transplantation 06/2017 - 01/2014
1	Heterologous Transplantation (Xenotransplantation) 05/2019
1	Radiotherapy 06/2017
1	Intravenous Administration 11/2016
1	Oral Administration 11/2015
1	Hematopoietic Stem Cell Transplantation 01/2015